Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis

Individuals with cystic fibrosis (CF) are given antimicrobials as prophylaxis against bacterial lung infection, which contributes to the growing emergence of multidrug resistant (MDR) pathogens isolated. Pathogens such as Pseudomonas aeruginosa that are commonly isolated from individuals with CF are...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Renee N., Tai, Anna S., Chang, Barbara J., Stick, Stephen M., Kicic, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829477/
https://www.ncbi.nlm.nih.gov/pubmed/33505366
http://dx.doi.org/10.3389/fmicb.2020.593988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829477/
https://www.ncbi.nlm.nih.gov/pubmed/33505366
http://dx.doi.org/10.3389/fmicb.2020.593988

Ejemplares similares